These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2613061

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9].
    Zanon C, Alluminio P, Margarita V, Sottimano C, Giuliani F, Neri G, Ballario F.
    Minerva Chir; 1992 Jan; 47(1-2):27-30. PubMed ID: 1553049
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [MCA and CA 15-3 in the follow-up of patients with breast cancer].
    Hammer J, Track C, Hohenwallner W, Seewald DH, Zoidl JP, Wimmer E.
    Strahlenther Onkol; 1992 Feb; 168(2):102-6. PubMed ID: 1542844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical study of CA15-3 in human breast cancer].
    Nihei M, Nomizu T, Tsuchiya A, Abe R.
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun 20; 22(5):987-95. PubMed ID: 3480326
    [No Abstract] [Full Text] [Related]

  • 11. [Tumor markers in metastatic breast carcinoma: correlations with clinical response].
    Winer Y, Martini MC, Pastorino G, Moraglio L, Vallauri M, Brondi P, Brema F.
    J Nucl Med Allied Sci; 1990 Jun 20; 34(4 Suppl):127-30. PubMed ID: 2092107
    [No Abstract] [Full Text] [Related]

  • 12. MCA performance in preoperative breast cancer patients.
    Donadeo A, Micelli G, Quaranta M, Atlante A, Schittulli F.
    Anticancer Res; 1995 Jun 20; 15(2):527-9. PubMed ID: 7763034
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L, Onetto M, Gardin G, Costanzi B, Giudici S, Vitiello E, Merlini L, Naso C, Zannini C, Paganuzzi M.
    Cancer Detect Prev; 1993 Jun 20; 17(3):411-5. PubMed ID: 8402728
    [Abstract] [Full Text] [Related]

  • 19. Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors.
    Heinze T, Schürenkämper P, Minguillon C, Lichtenegger W.
    Anticancer Res; 1997 Jun 20; 17(4B):2953-4. PubMed ID: 9329573
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.